| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |